FDA Issues Emergency Use Authorization for Impella RP as Therapy for COVID-19 Patients with Right Heart Failure (Cath Lab Digest)
The United States Food and Drug Administration has issued an emergency use authorization for Impella RP to include patients suffering from COVID-19 related right heart failure or decompensation, including pulmonary embolism.
The Society for Cardiovascular Angiography and Interventions
As the only U.S. professional medical society focused on invasive and interventional cardiology, SCAI is a trusted community providing guidance, representation, professional recognition, education, and research opportunities.
Get in touch
1100 17th Street NW, Suite 400, Washington, DC 20036